These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

714 related items for PubMed ID: 11257133

  • 1. Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) contributes to interferon gamma-dependent natural killer cell protection from tumor metastasis.
    Smyth MJ, Cretney E, Takeda K, Wiltrout RH, Sedger LM, Kayagaki N, Yagita H, Okumura K.
    J Exp Med; 2001 Mar 19; 193(6):661-70. PubMed ID: 11257133
    [Abstract] [Full Text] [Related]

  • 2. Sequential production of interferon-gamma by NK1.1(+) T cells and natural killer cells is essential for the antimetastatic effect of alpha-galactosylceramide.
    Smyth MJ, Crowe NY, Pellicci DG, Kyparissoudis K, Kelly JM, Takeda K, Yagita H, Godfrey DI.
    Blood; 2002 Feb 15; 99(4):1259-66. PubMed ID: 11830474
    [Abstract] [Full Text] [Related]

  • 3. Involvement of tumor necrosis factor-related apoptosis-inducing ligand in NK cell-mediated and IFN-gamma-dependent suppression of subcutaneous tumor growth.
    Takeda K, Smyth MJ, Cretney E, Hayakawa Y, Yamaguchi N, Yagita H, Okumura K.
    Cell Immunol; 2001 Dec 15; 214(2):194-200. PubMed ID: 12088418
    [Abstract] [Full Text] [Related]

  • 4. Critical contribution of IFN-gamma and NK cells, but not perforin-mediated cytotoxicity, to anti-metastatic effect of alpha-galactosylceramide.
    Hayakawa Y, Takeda K, Yagita H, Kakuta S, Iwakura Y, Van Kaer L, Saiki I, Okumura K.
    Eur J Immunol; 2001 Jun 15; 31(6):1720-7. PubMed ID: 11385616
    [Abstract] [Full Text] [Related]

  • 5. Tumor necrosis factor-related apoptosis-inducing ligand-mediated apoptosis is an important endogenous mechanism for resistance to liver metastases in murine renal cancer.
    Seki N, Hayakawa Y, Brooks AD, Wine J, Wiltrout RH, Yagita H, Tanner JE, Smyth MJ, Sayers TJ.
    Cancer Res; 2003 Jan 01; 63(1):207-13. PubMed ID: 12517799
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Interleukin-12 activates NK cells for IFN-gamma-dependent and NKT cells for IFN-gamma-independent antimetastatic activity.
    Hafner M, Falk W, Echtenacher B, Männel DN.
    Eur Cytokine Netw; 1999 Dec 01; 10(4):541-8. PubMed ID: 10586121
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Mechanisms of the antimetastatic effect in the liver and of the hepatocyte injury induced by alpha-galactosylceramide in mice.
    Nakagawa R, Nagafune I, Tazunoki Y, Ehara H, Tomura H, Iijima R, Motoki K, Kamishohara M, Seki S.
    J Immunol; 2001 Jun 01; 166(11):6578-84. PubMed ID: 11359810
    [Abstract] [Full Text] [Related]

  • 12. Increased susceptibility to tumor initiation and metastasis in TNF-related apoptosis-inducing ligand-deficient mice.
    Cretney E, Takeda K, Yagita H, Glaccum M, Peschon JJ, Smyth MJ.
    J Immunol; 2002 Feb 01; 168(3):1356-61. PubMed ID: 11801676
    [Abstract] [Full Text] [Related]

  • 13. Enhancement of the synthetic ligand-mediated function of liver NK1.1Ag+ T cells in mice by interleukin-12 pretreatment.
    Habu Y, Uchida T, Inui T, Nakashima H, Fukasawa M, Seki S.
    Immunology; 2004 Sep 01; 113(1):35-43. PubMed ID: 15312134
    [Abstract] [Full Text] [Related]

  • 14. Age-associated augmentation of the synthetic ligand- mediated function of mouse NK1.1 ag(+) T cells: their cytokine production and hepatotoxicity in vivo and in vitro.
    Inui T, Nakagawa R, Ohkura S, Habu Y, Koike Y, Motoki K, Kuranaga N, Fukasawa M, Shinomiya N, Seki S.
    J Immunol; 2002 Dec 01; 169(11):6127-32. PubMed ID: 12444115
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. TRAIL identifies immature natural killer cells in newborn mice and adult mouse liver.
    Takeda K, Cretney E, Hayakawa Y, Ota T, Akiba H, Ogasawara K, Yagita H, Kinoshita K, Okumura K, Smyth MJ.
    Blood; 2005 Mar 01; 105(5):2082-9. PubMed ID: 15536146
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. IFN-gamma-mediated inhibition of tumor angiogenesis by natural killer T-cell ligand, alpha-galactosylceramide.
    Hayakawa Y, Takeda K, Yagita H, Smyth MJ, Van Kaer L, Okumura K, Saiki I.
    Blood; 2002 Sep 01; 100(5):1728-33. PubMed ID: 12176894
    [Abstract] [Full Text] [Related]

  • 20. Difference in cytotoxicity against hepatocellular carcinoma between liver and periphery natural killer cells in humans.
    Ishiyama K, Ohdan H, Ohira M, Mitsuta H, Arihiro K, Asahara T.
    Hepatology; 2006 Feb 01; 43(2):362-72. PubMed ID: 16440347
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 36.